Literature DB >> 11516104

Regulation of the acute myeloid leukemia cell line OCI/AML-2 by endothelial nitric oxide synthase under the control of a vascular endothelial growth factor signaling system.

P Koistinen1, T Siitonen, P Mäntymaa, M Säily, V Kinnula, E R Savolainen, Y Soini.   

Abstract

It is generally accepted that the vascular endothelial growth factor (VEGF) signal system has no role in the maintenance of normal blood cell formation, although it obviously regulates the development of primitive hematopoiesis during an early stage of embryogenesis. The VEGF signaling pathway, however, might have some role in malignant hematopoiesis, since malignant hematopoietic cells, including acute myeloid leukemia (AML) cells, have been shown to express VEGF and its receptors. In endothelial cells, the VEGF/Flk-1/KDR signal system is a very important generator of nitric oxide (NO) through the activation of its downstream effectors phosphatidylinositol-3-OH-kinase (PI3-K), Akt kinase and endothelial NO synthase (eNOS). It is known that NO regulates hematopoiesis and modulates AML cell growth. The role of the VEGF signaling pathway in the control of AML cell growth through eNOS, however, has not been studied. By using the OCI/AML-2 cell line, which expresses VEGF receptor-2, ie Flk-1/KDR, eNOS and VEGF, as analyzed by flow cytometry, and produces VEGF into growth medium, as analyzed by ELISA, we showed that the Akt kinase and NOS activities in these cells were decreased by the inhibitors of VEGF, Flk-1/KDR and PI3-K, and NOS activity also by the direct inhibitor of NOS. The decreased NOS activity led to inhibition of clonogenic cell growth and, to some extent, induction of apoptosis. We also found that blast cells of bone marrow samples randomly taken from 14 AML patients uniformly expressed Flk-1/KDR and to varying degrees eNOS and VEGF, as analyzed by immunohistochemistry. We conclude that autocrine VEGF through Flk-1/KDR, by activating eNOS to produce NO through PI3-K/Akt kinase, maintains clonogenic cell growth in the OCI/AML-2 cell line. Since the patient samples did not express VEGF in all cases, it is possible that in vivo the regulatory connection between these two signal systems is also mediated via endocrine VEGF in addition to autocrine or paracrine VEGF.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11516104     DOI: 10.1038/sj.leu.2402217

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  16 in total

1.  Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma.

Authors:  Lin Zhang; Nuo Yang; Jose-Ramon Conejo Garcia; Alisha Mohamed; Fabian Benencia; Stephen C Rubin; David Allman; George Coukos
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  Activation of MDL-1 (CLEC5A) on immature myeloid cells triggers lethal shock in mice.

Authors:  Ricky Cheung; Fran Shen; Joseph H Phillips; Mandy J McGeachy; Daniel J Cua; Paul G Heyworth; Robert H Pierce
Journal:  J Clin Invest       Date:  2011-10-17       Impact factor: 14.808

3.  Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in association with neovascularization in human primary astrocytoma.

Authors:  Jian-Wei Pan; Ren-ya Zhan; Ying Tong; Yong-qing Zhou; Ming Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2005-07       Impact factor: 3.066

Review 4.  Tissue-specific endothelial cells: a promising approach for augmentation of soft tissue repair in orthopedics.

Authors:  Amir Lebaschi; Yusuke Nakagawa; Susumu Wada; Guang-Ting Cong; Scott A Rodeo
Journal:  Ann N Y Acad Sci       Date:  2017-12       Impact factor: 5.691

5.  Variations of brain endothelial nitric oxide synthase concentration in rat and mouse cortex.

Authors:  R Kenneth Czambel; Alexander Kharlamov; Stephen C Jones
Journal:  Nitric Oxide       Date:  2009-12-03       Impact factor: 4.427

Review 6.  Signaling and molecular basis of bone marrow niche angiogenesis in leukemia.

Authors:  R Shirzad; S Shahrabi; A Ahmadzadeh; K R Kampen; M Shahjahani; N Saki
Journal:  Clin Transl Oncol       Date:  2016-01-07       Impact factor: 3.405

Review 7.  Molecular pathways: not a simple tube--the many functions of blood vessels.

Authors:  Brent A Orr; Charles G Eberhart
Journal:  Clin Cancer Res       Date:  2014-07-29       Impact factor: 12.531

8.  Quantification of the specific membrane capacitance of single cells using a microfluidic device and impedance spectroscopy measurement.

Authors:  Qingyuan Tan; Graham A Ferrier; Brandon K Chen; Chen Wang; Yu Sun
Journal:  Biomicrofluidics       Date:  2012-08-13       Impact factor: 2.800

9.  The Role of PTEN in Tumor Angiogenesis.

Authors:  Stéphane Rodriguez; Uyen Huynh-Do
Journal:  J Oncol       Date:  2011-09-05       Impact factor: 4.375

Review 10.  Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors.

Authors:  Jason M Butler; Hideki Kobayashi; Shahin Rafii
Journal:  Nat Rev Cancer       Date:  2010-02       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.